These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23995360)

  • 21. Evaluation of palatability of 10 commercial amlodipine orally disintegrating tablets by gustatory sensation testing, OD-mate as a new disintegration apparatus and the artificial taste sensor.
    Uchida T; Yoshida M; Hazekawa M; Haraguchi T; Furuno H; Teraoka M; Ikezaki H
    J Pharm Pharmacol; 2013 Sep; 65(9):1312-20. PubMed ID: 23927469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet.
    Jung HA; Augsburger LL
    Drug Dev Ind Pharm; 2012 Jul; 38(7):825-36. PubMed ID: 22091970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of a new disintegration test system for the evaluation of orally disintegrating films.
    Takeuchi Y; Kawamoto M; Tahara K; Takeuchi H
    Int J Pharm; 2018 Dec; 553(1-2):281-289. PubMed ID: 30366069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disintegration of highly soluble immediate release tablets: a surrogate for dissolution.
    Gupta A; Hunt RL; Shah RB; Sayeed VA; Khan MA
    AAPS PharmSciTech; 2009; 10(2):495-9. PubMed ID: 19387843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutics, Drug Delivery and Pharmaceutical Technology: A New Test Unit for Disintegration End-Point Determination of Orodispersible Films.
    Low A; Kok SL; Khong Y; Chan SY; Gokhale R
    J Pharm Sci; 2015 Nov; 104(11):3893-903. PubMed ID: 27524687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A New Test Unit for Disintegration End-Point Determination of Orodispersible Films.
    Low A; Kok SL; Khong YM; Chan SY; Gokhale R
    J Pharm Sci; 2015 Nov; 104(11):3893-903. PubMed ID: 26296236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of Food Thickeners on the Disintegration, Dissolution, and Drug Activity of Rapid Oral-disintegrating Tablets].
    Tomita T; Kohda Y; Kudo K
    Yakugaku Zasshi; 2018; 138(3):353-356. PubMed ID: 29503428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
    Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation and evaluation of primaquine phosphate taste-masked rapidly disintegrating tablet.
    Shah PP; Mashru RC
    J Pharm Pharmacol; 2008 Oct; 60(10):1279-85. PubMed ID: 18812020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disintegration of sublingual tablets: proposal for a validated test method and acceptance criterion.
    Weda M; van Riet-Nales DA; van Aalst P; de Kaste D; Lekkerkerker JF
    Pharmeur Sci Notes; 2006 Dec; 2006(2):41-4. PubMed ID: 17691213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel Disintegration Tester for Solid Dosage Forms Enabling Adjustable Hydrodynamics.
    Kindgen S; Rach R; Nawroth T; Abrahamsson B; Langguth P
    J Pharm Sci; 2016 Aug; 105(8):2402-9. PubMed ID: 27422086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
    Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Research progress on the oral solid rapidly disintegrating dosage form].
    Shen L; Lin X; Xu DS; Feng Y
    Zhongguo Zhong Yao Za Zhi; 2005 Jan; 30(2):89-92. PubMed ID: 15714807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables.
    Mostafa HF; Ibrahim MA; Sakr A
    Pharm Dev Technol; 2013; 18(2):454-63. PubMed ID: 22881389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydrodynamic, mass transfer, and dissolution effects induced by tablet location during dissolution testing.
    Bai G; Armenante PM
    J Pharm Sci; 2009 Apr; 98(4):1511-31. PubMed ID: 18781589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of quick disintegrating calcium carbonate tablets.
    Fausett H; Gayser C; Dash AK
    AAPS PharmSciTech; 2000 Jul; 1(3):E20. PubMed ID: 14727906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose.
    Fukami J; Yonemochi E; Yoshihashi Y; Terada K
    Int J Pharm; 2006 Mar; 310(1-2):101-9. PubMed ID: 16434157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative evaluation of the disintegration of orally rapid disintegrating tablets by X-ray computed tomography.
    Otsuka M; Yamanaka A; Uchino T; Otsuka K; Sadamoto K; Ohshima H
    Chem Pharm Bull (Tokyo); 2012; 60(12):1502-7. PubMed ID: 23006519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.